作者
Chao Gao, Yue Cai, Kan Zhang, Lei Zhou, Yao Zhang, Xijing Zhang, Qi Li, Weiqin Li, Shiming Yang, Xiaoyan Zhao, Yuying Zhao, Hui Wang, Yi Liu, Zhiyong Yin, Ruining Zhang, Rutao Wang, Ming Yang, Chen Hui, William Wijns, J William McEvoy, Osama Soliman, Yoshinobu Onuma, Patrick W Serruys, Ling Tao, Fei Li
发表日期
2020/6/7
期刊
European heart journal
卷号
41
期号
22
页码范围
2058-2066
出版商
Oxford University Press
简介
Aims
It remains unknown whether the treatment of hypertension influences the mortality of patients diagnosed with coronavirus disease 2019 (COVID-19).
Methods and results
This is a retrospective observational study of all patients admitted with COVID-19 to Huo Shen Shan Hospital. The hospital was dedicated solely to the treatment of COVID-19 in Wuhan, China. Hypertension and the treatments were stratified according to the medical history or medications administrated prior to the infection. Among 2877 hospitalized patients, 29.5% (850/2877) had a history of hypertension. After adjustment for confounders, patients with hypertension had a two-fold increase in the relative risk of mortality as compared with patients without hypertension [4.0% vs. 1.1%, adjusted hazard ratio (HR) 2.12, 95% confidence interval (CI) 1.17–3.82, P = 0.013]. Patients with a history of hypertension …
学术搜索中的文章
C Gao, Y Cai, K Zhang, L Zhou, Y Zhang, X Zhang, Q Li… - European heart journal, 2020
